期刊文献+

4’-甲醚-黄芩素对绒毛膜癌JAR细胞c-myc表达的影响 被引量:6

Effect of 4'-Methery-scutellarein on c-myc Expression in Human Choriocarcinoma JAR Cells
原文传递
导出
摘要 目的探讨4’-甲醚-黄芩素(4-MS)诱导人绒毛膜癌JAR细胞凋亡的分子机制。方法应用透射电镜、流式细胞术、实时定量PCR法和Western blotting方法,体外观察4-MS对JAR细胞的影响。结果电镜下可见用药后JAR细胞凋亡的形态学改变;流式细胞术显示,随着作用时间和药物剂量的增加,早期凋亡细胞和坏死细胞增加,明显高于对照组(P<0.01)。20、40 mg.L-1 4-MS作用48 h后c-myc mRNA的表达量为0.87±0.12和0.45±0.08;c-myc蛋白的表达量是0.37±0.02和0.25±0.02,均低于对照组(P<0.01)。结论 4-MS诱导JAR细胞凋亡,其机制与降低c-myc的表达有关。 Objective To investigate the molecular mechanism of the apoptosis of human choriocarcinoma JAR cell line induced by 4'-methery-scutellarein(4-MS). Methods The techniques of transmission electron microscopy, flow cytometry, real-time quantitative polymerase chain reaction(PCR) and Western blotting were used to study the effect of 4-MS on JAR cells in vitro. Results The morphological changes of apoptosis appeared in JAR cells after treatment with 4-MS. The results of flow cytometry showed that 4-MS induced early apoptosis and cellular necrosis in both con- centration- and time-dependent manners, much higher than those in the control group(P 〈 0.01 ). After the JAR cells were treated by 4-MS at the concentrations of 20 and 40 mg L-1 for 48 h, c-myc mRNA expression level were 0.87±0.12 and 0.45±0.08, and that of e-myc protein were 0.37±0.02 and 0.25±0.02, respectively. Both the expression levels of e-mye mRNA and c-mye protein were lower than those in the control group(P 〈 0.01). Conclusion 4-MS can induce JAR cell apoptosis, and its mechanism is related to the deerease of c-mye expression.
出处 《中药新药与临床药理》 CAS CSCD 北大核心 2011年第5期501-505,共5页 Traditional Chinese Drug Research and Clinical Pharmacology
基金 江苏省自然科学基金资助项目(BK2003104)
关键词 4’-甲醚-黄芩素(4-MS) JAR细胞 凋亡 c—myc 4'-Methery-scutellarein(4-MS) JAR cell line Apoptosis c-myc
  • 相关文献

参考文献3

二级参考文献36

  • 1王家俊,罗莉,张立平,徐昌芬.马鞭草C部位对人绒癌JAR细胞hCG分泌的影响和作用机制[J].中国药科大学学报,2004,35(6):569-572. 被引量:12
  • 2张立平,夏邦亮,罗莉,徐昌芬.马鞭草C部位诱导人绒毛膜癌JAR细胞凋亡分子机制研究[J].中国肿瘤临床,2005,32(19):1089-1091. 被引量:10
  • 3杨隽钧,向阳,万希润,李勤,何凤权,杨秀玉.妊娠滋养细胞肿瘤患者的死亡原因及相关因素分析[J].中华妇产科杂志,2006,41(6):403-407. 被引量:9
  • 4Moodley M,Tunkyi K,Moodley J.Gestational trophoblastic syndrome:an audit of 112 patients.A South African experience.Int J Gynecol Cancer,2003,13:234-239.
  • 5Song HZ,Yang XY,Xiang Y.Forty-five year's experience of the treatment of choriocarcinoma and invasive mole.Int J Gynaecol Obstet,1998,60 Suppl 1:S77-83.
  • 6Kim SJ,Bae SN,Kim JH,et al.Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTF:25 years experiences of KRI-TRD.Int J Gynaecol Obstet,1998,60 Suppl 1:S85-96.
  • 7Ngan HY,Lopes AD,Lauder IJ,et al.An evaluation of the prognostic factors in metastatic gestational trophoblastic disease.Int J Gynecol Cancer,1994,4:36-42.
  • 8Weed JC Jr,Woodward KT,Hammond CB.Choriocarcinoma metastatic to the brain:therapy and prognosis.Semin Oncol,1982,9:208-212.
  • 9Weed JC Jr,Jelovsek FR,Tyrey L,et al.Intensive inpatient therapy and survival in gestational trophoblastic disease.Gynecol Oncol,1983,15:363-369.
  • 10杨秀玉,向阳,宋鸿钊,等.耐药及危重绒癌病例治疗的研究.中国医学科学院中国协和医科大学年鉴,2000.78-80.

共引文献24

同被引文献91

引证文献6

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部